ATAI Life Sciences Files 8-K on Financials
Ticker: ATAI · Form: 8-K · Filed: May 14, 2025 · CIK: 1840904
| Field | Detail |
|---|---|
| Company | Atai Life Sciences N.V. (ATAI) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, sec-filing
TL;DR
ATAI Life Sciences dropped an 8-K on May 14th, check it for financial updates.
AI Summary
On May 14, 2025, ATAI Life Sciences N.V. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing indicates that ATAI Life Sciences is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting financial condition and results, with no immediate negative or positive indicators in the provided text.
Key Players & Entities
- ATAI Life Sciences N.V. (company) — Registrant
- May 14, 2025 (date) — Date of report
- 001-40493 (company) — SEC File Number
FAQ
What specific financial information is being reported in this 8-K filing?
The provided excerpt states the filing concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific figures.
What is the exact date of this 8-K filing?
The filing's date of report is May 14, 2025.
What is the principal executive office address for ATAI Life Sciences N.V.?
The principal executive offices are located at Wallstraße 16, 10179 Berlin, Germany.
What is the SEC file number for ATAI Life Sciences N.V.?
The SEC file number is 001-40493.
Under which section of the Securities Exchange Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding ATAI Life Sciences N.V. (ATAI).